The potential of the emerging Glucagon-like Peptide-1 (GLP-1) Agonists in changing the current clinical practice guidelines is crucial to analyze, especially when it comes to real-world scenarios
It is not a medication, not a medical device, and does not prescribe or dispense anything
Stenlid R, Cerenius SY, Wen Q, Aydin BK, Manell H, Chowdhury A, et al
The first published tirzepatide injection site reaction case involved a patient who had tolerated dulaglutide for years without reactions, then developed a severe reaction covering the entire lower abdomen after switching to tirzepatide
Dehydration: Both the keto diet and GLP-1 medications can lead to increased urination, especially in the beginning
It is a prescription drug for its approved use